ClinicalTrials.govpublic full text
Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR
acute coronary syndrome (acs) undergoing percutaneous coronary intervention (pci), high bleeding risk, cyp2c19 genotype, acute coronary syndrome, de-escalation therapy, p2y12 inhibitor monotherapy, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 826278
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.